2019
DOI: 10.1093/ajcp/aqz144
|View full text |Cite
|
Sign up to set email alerts
|

Status of Histopathology Services in Ethiopia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Nevertheless, the facilitators and barriers to providing HER2 directed therapy to patients in SSA (including acceptability, accessibility, feasibility, and nancial toxicity) are understudied. Therefore, when developing manual IHC programs, multidisciplinary discussions involving pathology, medical, and surgical oncology teams are critical in overall program planning and phased implementation, with prioritization of disease focus and selective purchase of reagents to align with available treatment resources [14][15][16].…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, the facilitators and barriers to providing HER2 directed therapy to patients in SSA (including acceptability, accessibility, feasibility, and nancial toxicity) are understudied. Therefore, when developing manual IHC programs, multidisciplinary discussions involving pathology, medical, and surgical oncology teams are critical in overall program planning and phased implementation, with prioritization of disease focus and selective purchase of reagents to align with available treatment resources [14][15][16].…”
Section: Discussionmentioning
confidence: 99%